These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23897966)

  • 1. Should erlotinib be coadministered with whole-brain radiotherapy in patients with brain metastases and non-small-cell lung cancer?
    Chamberlain MC
    J Clin Oncol; 2013 Sep; 31(25):3164-5. PubMed ID: 23897966
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain metastasis in patients with non-small-cell lung cancer and epidermal growth factor receptor mutations.
    Bhatt VR; Kedia S; Kessinger A; Ganti AK
    J Clin Oncol; 2013 Sep; 31(25):3162-4. PubMed ID: 23897953
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to v.R. Bhatt et Al and m.C. Chamberlain.
    Welsh JW; McGovern SL; Wefel JS; Komaki R; Brown PD; Soh HE
    J Clin Oncol; 2013 Sep; 31(25):3165-6. PubMed ID: 23943829
    [No Abstract]   [Full Text] [Related]  

  • 4. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
    Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL
    Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gefitinib and erlotinib for non-small cell lung cancer patients who fail to respond to radiotherapy for brain metastases.
    Song Z; Zhang Y
    J Clin Neurosci; 2014 Apr; 21(4):591-5. PubMed ID: 24256883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation.
    Pan M; Santamaria M; Wollman DB
    Nat Clin Pract Oncol; 2007 Oct; 4(10):603-7. PubMed ID: 17898810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib: a case report.
    Nonagase Y; Okamoto K; Iwasa T; Yoshida T; Tanaka K; Takeda M; Kaneda H; Shimizu T; Tsurutani J; Nakagawa K
    Anticancer Drugs; 2016 Mar; 27(3):251-3. PubMed ID: 26575001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of whole-brain radiotherapy on remission of brain metastases.
    Nieder C
    J Clin Oncol; 2006 Aug; 24(24):4037; author reply 4037-8. PubMed ID: 16921062
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of intracranial metastases to epidermal growth factor receptor tyrosine kinase inhibitors: it may all depend on EGFR mutations.
    Costa DB; Kobayashi S
    J Clin Oncol; 2008 Feb; 26(4):686. PubMed ID: 18235134
    [No Abstract]   [Full Text] [Related]  

  • 10. Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.
    Yang RF; Yu B; Zhang RQ; Wang XH; Li C; Wang P; Zhang Y; Han B; Gao XX; Zhang L; Jiang ZM
    Braz J Med Biol Res; 2017 Nov; 51(1):e6073. PubMed ID: 29185589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation.
    Park SJ; Kim HT; Lee DH; Kim KP; Kim SW; Suh C; Lee JS
    Lung Cancer; 2012 Sep; 77(3):556-60. PubMed ID: 22677429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lung cancer: an update in 2010].
    Besse B; Vignot S; Soria JC
    Bull Cancer; 2010 Jan; 97(1):161-9. PubMed ID: 20028651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing osteoblastic lesions as a manifestation of a major response to gefitinib.
    Garfield D
    J Thorac Oncol; 2006 Oct; 1(8):859-60. PubMed ID: 17409972
    [No Abstract]   [Full Text] [Related]  

  • 14. Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer.
    Komaki R; Allen PK; Wei X; Blumenschein GR; Tang X; Lee JJ; Welsh JW; Wistuba II; Liu DD; Hong WK
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):317-24. PubMed ID: 25968826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis.
    Soon YY; Leong CN; Koh WY; Tham IW
    Radiother Oncol; 2015 Feb; 114(2):167-72. PubMed ID: 25583566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT & SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320: in regard to Sperduto et al.
    Robins HI; O'Neill A; Mehta M; Grossman S
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):809-10. PubMed ID: 23845832
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).
    Pesce GA; Klingbiel D; Ribi K; Zouhair A; von Moos R; Schlaeppi M; Caspar CB; Fischer N; Anchisi S; Peters S; Cathomas R; Bernhard J; Kotrubczik NM; D'Addario G; Pilop C; Weber DC; Bodis S; Pless M; Mayer M; Stupp R
    Eur J Cancer; 2012 Feb; 48(3):377-84. PubMed ID: 22093943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metastasis responding to gefitinib alone.
    Poon AN; Ho SS; Yeo W; Mok TS
    Oncology; 2004; 67(2):174-8. PubMed ID: 15539923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases.
    Altavilla G; Arrigo C; Santarpia MC; Galletti G; Picone G; Marabello G; Tomasello C; Pitini VV
    J Neurooncol; 2008 Oct; 90(1):31-3. PubMed ID: 18566747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases.
    Fan Y; Xu Y; Gong L; Fang L; Lu H; Qin J; Han N; Xie F; Qiu G; Huang Z
    Sci Rep; 2017 Mar; 7():45193. PubMed ID: 28332624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.